Transperineal radiofrequency interstitial tumor ablation of the prostate: Correlation of magnetic resonance imaging with histopathologic examination

Abstract

Objectives Radiofrequency (RF) energy has recently been employed to destroy human tissue in vivo. The purpose of this study was to investigate the safety of this approach in localized carcinoma of the prostate (CaP) and specifically, the predictability of lesions obtained with radiofrequency interstitial tumor ablation (RITA). Methods Using RITA, a total of 21 lesions were induced in 10 patients with localized CaP (mean age 70.4 years). RF was delivered transperineally under transrectal ultrasound (TRUS) guidance. All patients underwent endorectal magnetic resonance imaging (MRI) before and after treatment. Radical prostatectomy was performed in all patients 1 to 7 days after RITA. Three of the patients were treated with local anesthesia only. The predictability of the thermal lesion was assessed by correlating the findings of intraoperative TRUS, preand post-RITA endorectal MRI, and the histologic examination of the specimen. Results Postoperatively, patients were catheterized for an average of 1.8 days (1 to 3 days). Lesions of 2 × 2 × 2 cm were targeted. Average lesion diameters obtained on MRI were 2.08 ± 0.23 × 2.09 ± 0.36 × 2.28 ± 0.21 cm. Average lesion diameters defined by coagulative necrosis at histologic examination were 2.20 ± 0.23 × 2.10 ± 0.31 × 2.38 ± 0.14 cm. There were no statistically significant differences ( P = 0.377) between average lesion volume on MRI (5.37 ± 1.83 cm 3) and average lesion volume at histology (5.86 .63 cm 3). No complications or adverse events were noted. Conclusions In this Phase I study, RITA was shown to be safe and feasible, and to result in lesions that were predictable in size and location. MRI accurately visualized and verified the area of coagulative necrosis as documented at histology. The procedure is technically simple and can even be performed under local anesthesia.